Study of the Intermediate Metabolism in Children With Acute Lymphoblastic Leukemia (ALL)
NCT ID: NCT03035344
Last Updated: 2017-01-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
25 participants
OBSERVATIONAL
2015-05-31
2018-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mercaptopurine Therapeutic Drug Monitoring to Optimize the Maintenance Phase of Childhood ALL
NCT05811845
Applying Pediatric Regimens to Younger Adult Patients With Acute Lymphoblastic Leukemia (ALL)
NCT00131053
Dependence Receptors and Leukemia
NCT03278145
Allogeneic Stem Cell Transplantation in Chronic Lymphocytic Leukemia
NCT00337519
Safety and Efficacy of an Adult Acute Lymphoblastic Leukemia Chemotherapy for Adult Lymphoblastic Lymphoma
NCT00195871
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ALL paediatric patients
Metabolome study in children diagnosed with ALL after bone marrow biopsy
Metabolome study
Metabolome study in ALL patients compared to healthy controls
Healthy matched controls
Metabolome study in healthy children matched for gender and age with the patients group
Metabolome study
Metabolome study in ALL patients compared to healthy controls
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Metabolome study
Metabolome study in ALL patients compared to healthy controls
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
* Sampling method: Non-probability sample
1 Month
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aristotle University Of Thessaloniki
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Maria T. Papadopoulou
Principal investigator, MD, PhD candidate
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Athanassios Evangeliou, Prof
Role: STUDY_CHAIR
Aristotle University Of Thessaloniki
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aristotle University of Thessaloniki
Thessaloniki, , Greece
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Athanassios Evangeliou, Prof
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHILDHOOD ALL METABOLOMICS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.